2018
DOI: 10.1111/vru.12637
|View full text |Cite
|
Sign up to set email alerts
|

High dose hypofractionated frameless volumetric modulated arc radiotherapy is a feasible method for treating canine trigeminal nerve sheath tumors

Abstract: The aim of this prospective pilot study was to evaluate the feasibility and effectiveness of curative intent high dose hypofractionated frameless volumetric modulated arc radiotherapy for treatment of canine trigeminal peripheral nerve sheath tumors. Client-owned dogs with a presumptive imaging-based diagnosis of trigeminal peripheral nerve sheath tumor were recruited for the study during the period of February 2010 to December 2013. Seven dogs were enrolled and treated with high dose hypofractionated volumetr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 32 publications
1
9
0
Order By: Relevance
“…Observed clinical signs, neurological deficits, and MRI findings were similar to those previously reported . Although recent studies have focused on clinical outcomes after advanced treatment strategies, including stereotactic radiotherapy and volumetric‐modulated arc radiotherapy, the natural progression and survival of dogs with TNST after conservative treatment has rarely been reported. Although 2 of 27 dogs in which treatment was attempted underwent radiotherapy, the remaining 25 dogs included in our study received conservative medical treatment or no specific treatment at all.…”
Section: Discussionsupporting
confidence: 81%
“…Observed clinical signs, neurological deficits, and MRI findings were similar to those previously reported . Although recent studies have focused on clinical outcomes after advanced treatment strategies, including stereotactic radiotherapy and volumetric‐modulated arc radiotherapy, the natural progression and survival of dogs with TNST after conservative treatment has rarely been reported. Although 2 of 27 dogs in which treatment was attempted underwent radiotherapy, the remaining 25 dogs included in our study received conservative medical treatment or no specific treatment at all.…”
Section: Discussionsupporting
confidence: 81%
“…It is now possible to perform irradiation at a dose rate higher than 400 cGy/min using a linac. However, we considered our dose rate more appropriate, since the intensity‐modulated radiation therapy creates a very complicated irradiation field and takes more time to deliver the dosage to the target (with the effective dose rate of around 200 cGy/min or less, depending on the degree of modulation and complexity of the plan) . Furthermore, increment of dose rate 200 to 400 cGy affects only less than 1% for cellular survival fraction.…”
Section: Discussionmentioning
confidence: 99%
“…There is little documentation of pseudoprogression in the veterinary literature. In one small study investigating the feasibility and effectiveness of curative intent high‐dose hypofractionated frameless volumetric modulated arc radiotherapy for treatment of canine trigeminal peripheral nerve sheath tumours, one of the seven dogs enrolled experienced possible pseudoprogression with transient increase in tumour size despite substantial clinical improvement 10. To the authors’ knowledge, this is the only documented case of suspect pseudoprogression in the veterinary literature.…”
Section: Discussionmentioning
confidence: 97%